KomturKomtur_Logo.svg
Contact

Practical Access Strategy for Real‑World Launch

Market access starts long before launch. Komtur’s Market Access Consulting helps pharma and biotech build strategies that are as practical as they are ambitious. We connect clinical intent with the realities of distribution, reimbursement contexts, and adoption. Our work brings pricing and regulatory insights together with channel planning, launch design, and data readiness.

Whether entering an untested market, planning a staged rollout, or building a value case for an orphan therapy, Komtur charts a clear path from development to delivery. Our guidance is grounded in real operations, so strategy moves to execution without friction.

We shape early access and market entry by clarifying import and Importer of Record frameworks, stress testing supply routes, assessing pricing and reimbursement readiness, mapping stakeholders, and designing launch models and field infrastructure. From early value messaging to infrastructure planning, our insight is built to ship, not just to slide.

About Market Access Consulting

Komtur’s consulting is for teams that want clarity early, before decisions are locked in. Our perspective comes from on-the-ground implementation across markets and day-to-day work with regulatory, logistics, and provider networks. Every engagement is tailored, collaborative, and focused on turning strategy into tangible access results.

  • Access-Ready Strategy Development

    Plans that factor policy, pricing, logistics, timing, and market context, so access is achievable, not aspirational.

  • Execution-Focused Insight

    We focus on the details that matter. Importer of Record setup, controlled distribution, stakeholder engagement, and field readiness to prevent downstream delays.

  • Reimbursement Landscape Awareness

    Input on feasibility of local pricing and reimbursement models, value dossier needs, and early payer positioning, especially for rare or high‑cost therapies.

  • Stakeholder Mapping & Coordination

    Identify and prepare the right networks across the value chain, from providers to payers to patient groups.

  • Embedded into Service Execution

    Because consulting is integrated with Komtur’s access, distribution, and PSP delivery, recommendations gain immediate operational traction.

Our Market Access Consulting Services

Why Komtur?

  • One Platform, Integrated Access

    Komtur orchestrates access across regulatory, operational, stakeholder, and medical functions. We deliver Early Access, Compassionate Use, and Patient Support services in one sponsor-aligned, patient-centric solution.

  • Lifecycle Continuity from Phase II to Post-Launch

    Our models support access from first patient supply in Early or Compassionate Use through to commercialization. This enables agile launch sequencing and consistent patient continuity across stages.

  • Global Reach with Local Adaptation

    With 18 affiliates and deep regional expertise, we tailor implementation country by country. This helps ensure local realities don’t become global bottlenecks.

  • Trusted in Complex Access Environments

    Biotech and rare disease innovators rely on Komtur to bridge clinical readiness with operational access, even when data is limited or infrastructure is fragmented.

  • Beyond Access: Supporting the Full Patient Journey

    Our PSPs deliver education, coordination, and care continuity. We help patients start and stay on therapy while reinforcing outcomes and long-term treatment success.

Start your market access plan

Let Komtur’s experts guide your therapy to market success with customized, patient-centric market access strategies.

“quote XYZ .”